Qiu, Yunguang <br/><br/>
TREK Channel Family Activator with a Well-Defined Structure-Activation Relationship for Pain and Neurogenic Inflammation.  [electronic resource] 

 -  Journal of medicinal chemistry  04 2020 
 - 3665-3677 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1520-4804 
<br/><br/><label>Standard No.: </label>10.1021/acs.jmedchem.9b02163  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analgesics--metabolism<br/>Animals<br/>Anti-Inflammatory Agents--metabolism<br/>Benzothiazoles--metabolism<br/>Binding Sites<br/>Ganglia, Spinal--drug effects<br/>HEK293 Cells<br/>Humans<br/>Male<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Molecular Docking Simulation<br/>Molecular Structure<br/>Neurogenic Inflammation--drug therapy<br/>Pain--drug therapy<br/>Pancreatitis--drug therapy<br/>Potassium Channels, Tandem Pore Domain--agonists<br/>Protein Binding<br/>Rats, Sprague-Dawley<br/>Structure-Activity Relationship